Mirae Asset Global Etfs Holdings Ltd. Travere Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 49,946 shares of TVTX stock, worth $969,451. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,946
Previous 40,465
23.43%
Holding current value
$969,451
Previous $566,000
53.71%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TVTX
# of Institutions
214Shares Held
94.3MCall Options Held
1.2MPut Options Held
778K-
Black Rock Inc. New York, NY7.64MShares$148 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.36MShares$143 Million1.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$131 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.97MShares$96.5 Million3.46% of portfolio
-
Macquarie Group LTD Australia, C34.26MShares$82.7 Million0.09% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.25B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...